$46.06 Nov 9, 2026 · market cap $4.7B
Edgewise Therapeutics trades at $46. We don't have a valuation for it yet.
6 of 121 tracked investors hold it · Q2 2026 13F filings
Estimates from SEC filings and market data; the verdict is AI research. Not investment advice. Get the iPhone app · Get the Android app